Background The responses to programmed cell death protein 1 (PD-1)-based therapy in advanced endometrial cancer are heterogeneous. The cellular programs associated with such respon
Liver involvement in ovarian cancer is often treated as a single clinical entity, although liver-surface implants and parenchymal deposits occupy different anatomical settings and
Oral squamous cell carcinoma (OSCC) is one of the leading causes of cancer morbidity and mortality globally, and prognosis is closely related to the stage at diagnosis. Although ad
Artificial Intelligence (AI) is revolutionizing gene therapy from an empirical and iterative process to a predictive, data-driven and increasingly intelligent therapeutic developme
Background Radiotherapy (RT) is evolving from local cytotoxicity to systemic immunomodulation. Acting as an in situ vaccine, RT initiates antitumor immunity via immunogenic cell de
Drug repurposing represents a pragmatic strategy for patients with cancer who have limited standard-of-care options. Traditional in silico or functional repurposing approaches ofte
This is an exploratory multi-omics study generating mechanistic hypotheses about shared genetic pathways in depression and obesity, with inconclusive bidirectional evidence and candidate genes requiring experimental validation.